Biostar Pharmaceuticals, Inc. (BSPM)
OTCMKTS
· Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
May 12, 2025, 4:00 PM EDT
Biostar Pharmaceuticals Revenue
Biostar Pharmaceuticals had revenue of $317.79K in the twelve months ending September 30, 2017, down -91.86% year-over-year. In the year 2016, Biostar Pharmaceuticals had annual revenue of $2.38M, down -91.21%.
Revenue (ttm)
317.79K
Revenue Growth
-91.86%
P/S Ratio
0.00
Revenue / Employee
1.59K
Employees
200
Market Cap
264.00
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2016 | 2.38M | -24.75M | -91.21% |
Dec 31, 2015 | 27.13M | -34.29M | -55.83% |
Dec 31, 2014 | 61.42M | 8.69M | 16.48% |
Dec 31, 2013 | 52.73M | 3.41M | 6.92% |
Dec 31, 2012 | 49.32M | -42.65M | -46.37% |
Dec 31, 2011 | Pro | Pro | Pro |
Dec 31, 2010 | Pro | Pro | Pro |
Dec 31, 2009 | Pro | Pro | Pro |
Dec 31, 2008 | Pro | Pro | Pro |
Dec 31, 2007 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo Inc. | 1.73B |
Veradigm | 588.02M |
Tian'an Technology Group | 1.78M |
Glass House Brands | 200.90M |
Elite Pharmaceuticals | 70.00M |
Northwest Biotherapeutics | 1.38M |
BioStem Technologies | 301.83M |
American Oncology Network | 1.76B |